At a Glance
| Bromo-DragonFLY | DOI | |
|---|---|---|
| Class | Psychedelic | Psychedelic |
| Common Dose (oral) | 300–500 µg | 1–2 mg |
| Total Duration | 11–25 hrs | 2.5–5 hrs |
| Routes | oral | oral |
| Effects | 66 documented | 66 documented |
Bromo-DragonFLY, a Psychedelic, and DOI, a Psychedelic, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Psychedelics, meaning they share a common pharmacological foundation. They share 53 documented effects in common, with 13 effects unique to Bromo-DragonFLY and 13 unique to DOI. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Bromo-DragonFLY | DOI | |
|---|---|---|
| Class | Psychedelic | Psychedelic |
| Common Dose (oral) | 300–500 µg | 1–2 mg |
| Total Duration | 11–25 hrs | 2.5–5 hrs |
| Routes | oral | oral |
| Effects | 66 documented | 66 documented |
| Level | Bromo-DragonFLY | DOI |
|---|---|---|
| Threshold | 75 µg | 0.5 mg |
| Light | 100–300 µg | 0.5–1 mg |
| Common | 300–500 µg | 1–2 mg |
| Strong | 500–750 µg | 2–3 mg |
| Heavy | 750 µg | 3 mg |
Bromo-DragonFLY
DOI
No direct interaction data available between these substances. This does not mean the combination is safe.
No dangerous interactions recorded.
No dangerous interactions recorded.